Literature DB >> 16883657

Treatment options for refractory angina in patients who are not candidates for revascularization.

C Richard Conti1.   

Abstract

Patients with refractory angina are those for whom medical therapy has failed to eradicate the angina completely and who have persistent symptoms that are stable but limit their activities of daily living. Approach to management must include the elimination of the secondary causes of this condition and maximum medical therapy, and if angina persists, the consideration of other strategies. Controversy exists regarding the value of transmural myocardial laser revascularization. Enhanced external counterpulsation is clinically effective in approximately 70% of patients. Spinal cord stimulation is not being used clinically in the United States. In the United States, it is still an investigational procedure that is currently being evaluated prospectively in a randomized trial. Ranolazine, an inhibitor of sodium-dependent calcium overload, may prove to be useful in patients with refractory angina.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16883657     DOI: 10.1007/s11886-006-0058-2

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  15 in total

1.  EECP-enhanced external counterpulsation.

Authors:  C R Conti
Journal:  J Am Coll Cardiol       Date:  1999-06       Impact factor: 24.094

2.  Transmyocardial laser revascularization.

Authors:  R A Lange; L D Hillis
Journal:  N Engl J Med       Date:  1999-09-30       Impact factor: 91.245

3.  The AbCs of modem management of chronic stable angina pectoris.

Authors:  C Richard Conti
Journal:  Clin Cardiol       Date:  2005-03       Impact factor: 2.882

4.  Comparison of transmyocardial revascularization with medical therapy in patients with refractory angina.

Authors:  K B Allen; R D Dowling; T L Fudge; G P Schoettle; S L Selinger; D M Gangahar; W W Angell; M R Petracek; C J Shaar; W W O'Neill
Journal:  N Engl J Med       Date:  1999-09-30       Impact factor: 91.245

5.  The multicenter study of enhanced external counterpulsation (MUST-EECP): effect of EECP on exercise-induced myocardial ischemia and anginal episodes.

Authors:  R R Arora; T M Chou; D Jain; B Fleishman; L Crawford; T McKiernan; R W Nesto
Journal:  J Am Coll Cardiol       Date:  1999-06       Impact factor: 24.094

6.  Clinical outcome of patients treated with spinal cord stimulation for therapeutically refractory angina pectoris. The Working Group on Neurocardiology.

Authors:  I A TenVaarwerk; G A Jessurun; M J DeJongste; C Andersen; C Mannheimer; T Eliasson; W Tadema; M J Staal
Journal:  Heart       Date:  1999-07       Impact factor: 5.994

7.  Electrical stimulation versus coronary artery bypass surgery in severe angina pectoris: the ESBY study.

Authors:  C Mannheimer; T Eliasson; L E Augustinsson; C Blomstrand; H Emanuelsson; S Larsson; H Norrsell; A Hjalmarsson
Journal:  Circulation       Date:  1998-03-31       Impact factor: 29.690

8.  Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina.

Authors:  Bernard R Chaitman; Sandra L Skettino; John O Parker; Peter Hanley; Jaroslav Meluzin; Jerzy Kuch; Carl J Pepine; Whedy Wang; Jeanenne J Nelson; David A Hebert; Andrew A Wolff
Journal:  J Am Coll Cardiol       Date:  2004-04-21       Impact factor: 24.094

9.  Effects of spinal cord stimulation on myocardial ischaemia during daily life in patients with severe coronary artery disease. A prospective ambulatory electrocardiographic study.

Authors:  M J de Jongste; J Haaksma; R W Hautvast; H L Hillege; P W Meyler; M J Staal; J E Sanderson; K I Lie
Journal:  Br Heart J       Date:  1994-05

10.  Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties.

Authors:  Charles Antzelevitch; Luiz Belardinelli; Andrew C Zygmunt; Alexander Burashnikov; José M Di Diego; Jeffrey M Fish; Jonathan M Cordeiro; George Thomas
Journal:  Circulation       Date:  2004-08-09       Impact factor: 29.690

View more
  2 in total

Review 1.  Enhanced external counterpulsation for chronic angina pectoris.

Authors:  Fawzi Amin; Amani Al Hajeri; Birol Civelek; Zbys Fedorowicz; Bruce M Manzer
Journal:  Cochrane Database Syst Rev       Date:  2010-02-17

2.  Percutaneous coronary revascularization in patients with formerly "refractory angina pectoris in end-stage coronary artery disease" - not "end-stage" after all.

Authors:  Thomas W Jax; Ansgar J Peters; Ahmed A Khattab; Matthias P Heintzen; Frank-Chris Schoebel
Journal:  BMC Cardiovasc Disord       Date:  2009-08-28       Impact factor: 2.298

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.